The process of metastasis requires migration of tumor cells from the primary tumor into the vasculature and the target tissue. 1 Studies with a variety of tumor types have shown that metastatic tumor cells are more highly motile than are nonmetastatic cells. [2][3][4][5] Cellular migration is influenced by the degree of adhesiveness to a substratum, signaling through integrins, and active turnover of focal adhesions. 6,7 There is, however, a fine balance between adherence/detachment and motility. A strong shift toward focal adhesion formation results in strong adherence with little migration, whereas excessive loss of adherence results in the inability to navigate across the substratum. Interactions with a substratum leads to the formation and stabilization of focal adhesions, where the actin skeleton converges with integrins and an interconnection of protein complexes. 6,8 Among the focal adhesion proteins that mediates communication through integrins during interaction with the substratum is the cytosolic tyrosine kinase FAK. 6,9 When FAK activity is reduced, cellular adhesiveness is diminished 10. During motility, the levels of membrane-associated FAK decline. 11 In adherent cells, FAK is complexed with Src within stable focal adhesions. 6 The tyrosine kinase Src (pp60c-Src) is a prototype of a family of tyrosine kinases that also includes Fyn, Lyn, Yes. Src Y527 residue (Y530 in humans) regulates Src activity. 7,12 When phosphorylated, Y527 inactivates Src by undergoing a conformational change and binding with the Src SH2 domain. FAK complexing with Src is important in Src activation and stabilization of focal adhesions, Src activation can also increase turnover of focal adhesions and increase motility. [13][14][15] An in vivo role of FAK or Src in cancer invasion has been suggested by their increased levels in malignancies. 16 Key in the formation of stable adhesions is association of FAK and Src with paxillin. Paxillin is a 68 kDa adaptor protein that binds a multitude of structural and signaling molecules within focal adhesions. The ability of paxillin to facilitate interaction between molecules of the focal adhesions is regulated by its level of serine and tyrosine phosphorylation. 17 Focal adhesion formation and cellular adhesion are accompanied by tyrosine phosphorylation of paxillin, 18,19 whereas the breakdown of focal adhesions and loss of adherence are accompanied by tyrosine dephosphorylation of paxillin. 20,21 Blocking tyrosine phosphorylation of paxillin results in failure to form organized stress fibers and focal adhesions, and defective cellular adherence. 22 In contrast, serine phosphorylation of paxillin has been associated with redistribution of paxillin from the tyrosine-phosphorylated focal adhesions and increased cell scattering. 23 Our studies with a murine Lewis lung carcinoma model have shown regulation of cell migration by the serine/threonine protein phosphatase PP-2A. 3,24 More highly motile and metastatic tumor cells have diminished PP-2A activity. Inhibition of PP-2A activity wit...
Tumor neovascularization is necessary for the progressive development of all solid tumors, including head and neck squamous cell carcinomas (HNSCCs). The angiogenic process includes increased endothelial cell motility. Our prior studies have shown the importance of protein phosphatase-2A (PP-2A) in restricting endothelial cell motility. Because motility is regulated by the polymerization/depolymerization of the cellular cytoskeleton, the present study defined the interrelationship between PP-2A and the cytoskeleton during endothelial cell responses to HNSCC-derived angiogenic factors. PP-2A was shown to colocalize with microtubules of unstimulated endothelial cells. However, exposure to HNSCC-derived products resulted in a more diffuse distribution of PP-2A staining and a loss of filamentous tubulin. The feasibility of pharmacologically preventing this cytoskeletal disorganization as a means of blocking tumor-induced angiogenesis was tested. This was accomplished by use of 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] and all-trans -retinoic acid to indirectly stimulate PP-2A activity through their capacity to elevated intracellular levels of the second messenger ceramide. Pretreatment of endothelial cells with either 1,25(OH)(2)D(3) or retinoic acid prevented the cytoskeletal disorganization that otherwise occurs in endothelial cells on exposure to HNSCC-derived products. These studies support the feasibility of using elevation of PP-2A to prevent the morphogenic component of the angiogenic process that is stimulated by HNSCC-derived factors.
Tumor neovascularization is necessary for the progressive development of all solid tumors, including head and neck squamous cell carcinomas (HNSCCs). The angiogenic process includes increased endothelial cell motility. Our prior studies have shown the importance of protein phosphatase-2A (PP-2A) in restricting endothelial cell motility. Because motility is regulated by the polymerization/depolymerization of the cellular cytoskeleton, the present study defined the interrelationship between PP-2A and the cytoskeleton during endothelial cell responses to HNSCC-derived angiogenic factors. PP-2A was shown to colocalize with microtubules of unstimulated endothelial cells. However, exposure to HNSCC-derived products resulted in a more diffuse distribution of PP-2A staining and a loss of filamentous tubulin. The feasibility of pharmacologically preventing this cytoskeletal disorganization as a means of blocking tumor-induced angiogenesis was tested. This was accomplished by use of 1alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] and all-trans -retinoic acid to indirectly stimulate PP-2A activity through their capacity to elevated intracellular levels of the second messenger ceramide. Pretreatment of endothelial cells with either 1,25(OH)(2)D(3) or retinoic acid prevented the cytoskeletal disorganization that otherwise occurs in endothelial cells on exposure to HNSCC-derived products. These studies support the feasibility of using elevation of PP-2A to prevent the morphogenic component of the angiogenic process that is stimulated by HNSCC-derived factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.